No attachments available.
ORV Baits - Intent to Sole Source
Contact and place of performance
Charmion Harris
Duluth, GA 30096
USA
Boehinger-Ingelheim Animal Health USA, Inc. is the only entity in the United States that has a licensed oral rabies vaccine that can be produced in high volume (up to 10 million baits annually to meet long-term goals of rabies elimination in wild carnivores) and delivered in different bait formats on the required schedule for rabies control in the United States.
The United States Department of Agriculture, Animal and Plant Health Inspection Service (APHIS) issued an award notice for oral rabies vaccine (ORV) baits under solicitation number 12639524R0047. The procurement is classified under NAICS 325414 for Biological Product (except Diagnostic) Manufacturing and PSC 6505 for Drugs and Biologicals. Performance is located in Duluth, Georgia, and the primary point of contact is Charmion Harris.
The agency identified Boehringer-Ingelheim Animal Health USA, Inc. as the sole source for this requirement. This entity is the only provider in the United States maintaining a licensed oral rabies vaccine capable of high-volume production, reaching up to 10 million baits annually. This production capacity is necessary to meet the long-term federal goals of eliminating rabies in wild carnivores. The provider also maintains the capability to deliver the vaccine in various bait formats according to the established schedule for national rabies control efforts.
Published on June 24, 2024, this award notice identifies the specific capabilities required to support the APHIS mission. The notice reflects the synthesis of specialized biological manufacturing needs and the restricted availability of licensed vaccines that meet high-volume delivery standards. There are zero attachments associated with this notification.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.